(Reuters) - The second patient to receive an artificial heart made by French firm Carmat is leading a normal life including physical exercise, eight months after his transplant, the 69-year-old man told weekly Le Journal du Dimanche in an interview.
Carmat is conducting trials of its heart device that is designed as a permanent implant that can extend the life of patients without them having to wait for a human heart donor.
The company’s first transplant patient, a 76-year-old man, died in March last year, two-and-a-half months after his operation.
Help employers find you! Check out all the jobs and post your resume.
